Cohen Capital Management, Inc. Verastem, Inc. Transaction History

Cohen Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 05, 2020	SELL	$0.86 - $1.44 $412,045 - $689,937	-479,123 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$1.25 - $3.14 $281,953 - $708,267	225,563 Added 88.96%	479,123 $723,000
Q4 2018 Feb 08, 2019	BUY	$3.23 - $7.01 $12,790 - $27,759	3,960 Added 1.59%	253,560 $852,000
Q3 2018 Nov 09, 2018	BUY	$6.86 - $9.97 $1.71 Million - $2.49 Million	249,600 New	249,600 $1.81 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $823M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cohen Capital Management, Inc. with notifications on news.